CTXR

CITIUS PHARMACEUTICALS INC

Healthcare | Micro Cap

-$1.96

EPS Forecast

$42.22

Revenue Forecast

Announcing earnings for the quarter ending 2024-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$1.96

Revenue Forecast:

$42.22

EPS Surprise Forecast:

$0.042

Revenue Surprise Forecast:

-$10

Post-release price volatility - Very high

Post-release Overnight Move:

±10.3%

Post-release 1-week Move:

Odds of beating consensus

Probability of beating EPS consensus:

Probability of beating revenue consensus:

Probability of beating both EPS & revs consensus:

Probability of missing both EPS & revs consensus:

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

Beta (β)

Forward Looking Beta (β):

Earnings volatility

EPS standard deviation:

Revenue standard deviation:

As % of share price:

As % of market cap:

Confidence intervals and percentiles

EPS 95th %ile:

Revenue 95th %ile:

EPS 75th %ile:

Revenue 75th %ile:

EPS 25th %ile:

Revenue 25th %ile:

EPS 5th %ile:

Revenue 5th %ile:

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

Stock's bid-ask spread

Bid-ask per $10K:

Bid-ask per Share: